NEW RESEARCHLIFESTYLE
Researchers are working on new formulations of GLP-1 drugs that could reduce how often patients need to take them — potentially shifting from weekly injections to just once a quarter. This could make the medications easier to stick with and less burdensome for patients who find frequent dosing challenging. It’s still in development, but it signals where treatment is headed in the next few years.
Source: Bioxconomy
Comments are closed.